Autoinjector preference among patients with multiple sclerosis: results from a national survey

PURPOSE: Autoinjectors are well-established in supporting multiple sclerosis (MS) therapy. This market survey was aimed at investigating patients’ rating of three devices for subcutaneous interferon beta formulations: the electronic autoinjectors Betaconnect(®) and RebiSmart™ as well as the mechanic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Patient Prefer Adherence
Autori principali: Limmroth, V, Reischl, J, Mann, B, Morosov, X, Kokoschka, A, Weller, I, Schreiner, T
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548304/
https://ncbi.nlm.nih.gov/pubmed/28831243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S137741
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi